Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells.

Hanieh HamzaOmar MohafezVillianur Ibrahim Hairul-IslamAbdullah AlzahraniMohammad Bani IsmailKrishnaraj Thirugnanasambantham

Published in: PloS one (2016)

Taken together, the results introduce Flavipin as a novel Ahr agonist, and provide first evidences on its inhibitory effects on cancer cell motility, suggesting Flavipin as a candidate to control cell invasiveness in breast cancer patients.

Keyphrases

breast cancer cells
single cell
signaling pathway
cell therapy
biofilm formation
stem cells
staphylococcus aureus
pseudomonas aeruginosa
candida albicans